Business Description
Mira Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US60458C1045
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3529 | |||||
Equity-to-Asset | 0.83 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.1 | |||||
9-Day RSI | 57.28 | |||||
14-Day RSI | 53.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.7 | |||||
Quick Ratio | 5.7 | |||||
Cash Ratio | 5.41 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -0.65 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -410.49 | |||||
ROA % | -281.12 | |||||
ROIC % | -502.07 | |||||
ROC (Joel Greenblatt) % | -11220.55 | |||||
ROCE % | -294.38 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 4.14 | |||||
Price-to-Tangible-Book | 4.21 | |||||
EV-to-EBIT | -1.07 | |||||
EV-to-EBITDA | -1.07 | |||||
EV-to-FCF | -2.12 | |||||
Price-to-Net-Current-Asset-Value | 4.21 | |||||
Price-to-Net-Cash | 4.71 | |||||
Earnings Yield (Greenblatt) % | -93.46 | |||||
FCF Yield % | -34.45 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mira Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.792 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 53.9 | ||
14-Day ATR (€) | 0.077598 | ||
20-Day SMA (€) | 0.721 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 0.545 - 1.85 | ||
Shares Outstanding (Mil) | 14.78 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mira Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mira Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Mira Pharmaceuticals Inc Frequently Asked Questions
What is Mira Pharmaceuticals Inc(FRA:K6S)'s stock price today?
When is next earnings date of Mira Pharmaceuticals Inc(FRA:K6S)?
Does Mira Pharmaceuticals Inc(FRA:K6S) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |